Nobuhisa Hagiwara
Department Other, Other Position |
|
Language | English |
Title | Differences in the usefulness of aggressive lipid-lowering therapy among single-vessel and multi-vessel coronary artery disease patients: HIJ-PROPER sub-study |
Conference | ESC Congress 2019 |
Promoters | European Society of Cardiology |
Conference Type | International society and overseas society |
Presentation Type | Poster notice |
Lecture Type | General |
Publisher and common publisher | OGISO Masataka, ◎NOMURA Hidekimi, NAKAZAWA Mayui, WATANABE Erisa, SEKIGUCHI Haruki, ARASHI Hiroyuki, YAMAGUCHI Junichi, OGAWA Hiroshi, HAGIWARA Nobuhisa, |
Date | 2019/08/31 |
Venue (city and name of the country) |
Paris, FRANCE |
Summary | Poster Session 1: Acute coronary syndromes, coronary artery disease: treatment
Topic : European Society Of Cardiology Session Type : Poster Session Conclusion: This study showed that ACS patients with SVD enjoyed significantly greater benefits from pitavastatin + ezetimibe therapy compared with pitavastatin monotherapy, whereas the patients with MVD did not. High rate of revascularization in acute phase of ACS might affect the efficacy of aggressive lipidlowering therapy and our results in the present study suggest different treatment approach would be necessary in ACS patients with MVD in modern early invasive strategy era. |